 |
|
|
|
Home Page : www.otcjournal.com
Email Questions or Comments To:
editor@otcjournal.com
To
OTC Journal Members:
 |
The Pickle
(OTC BB: SPKL): Spicy on the Top Line |
|
The Spicy Pickle June quarterly
results were out today, and they were spot on what I was expecting. A huge
percentage increase in the top line, and huge expenses in the quarter as
they built three new stores and bought back four stores from a franchisee.
My expectations are for continued top line improvement over the coming
quarters, but much lower expenses as they won't be building or buying more
company stores for the forseeable future.
Here's a few highlights:
-
Revenues- The Good News-
the Top Line was $1.225 million- up 280% over the same quarter
in 2007, and up 143% from Q1 of '08. Pretty impressive
growth all the way around.
-
Profits- SPKL lost
$1.6
million in the quarter- to me, this doesn't seem unreasonable in a
quarter where you had to build out 3 new stores and buy 4 from existing
franchisees. Some of that investment now appears on the balance sheet in
the form of property and equipment, which increased from $700k to $2 million.
-
Balance Sheet- Cash reserves
dropped from $5.4 million to $2.1 million. For a company
this size- that's a big drop. However, most of that money is not gone.
It is now found in the form of 7 company owned stores that are generating
revenues and cash flow everyday. They invested the money they raised in
December at $.85 per share.
Interesting Note: In my
view, of particular interest is an item most investors could not figure
out on their own. Back in December SPKL issued 705 shares
of convertible preferred in return for a $6 million financing. The preferred
units convert into common stock at a fixed price of $.85.
Originally, there were 705
shares issued. As of the June 30, there were still 650 of those
preferred units remaining unconverted, a number of which are in my Defined
Benefit Plan. This means 80% of the convertible holders still like their
chances for making money with a cost basis of $.85.
On a go forward basis, I would expect
the top line to keep growing, but the cash burn rate to drop considerably.
I believe they will continue to burn cash for a couple more quarters, and
then turn cash flow positive in 2009. They could run a little low on capital
before turning profitable, but this isn't a biotech company. Cash comes
in everyday, and its growing.
There is very little reaction to
today's news in the market. The stock continues to trade in the low $.60
range on very anemic volume- typical for the end of August. Any aspect
of today's financial filing that could be construed as negative is probably
already priced into the stock.
I would expect SPKL to pick
up nicely and and start to behave quite a bit better as we head into the
Fall.
Home Page : www.otcjournal.com
Email Questions or Comments To:
editor@otcjournal.com
|
|
Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription.
Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.
To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best
way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable
email newsletter delivery.
Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.
If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.
| |
Ensure Newsletter Delivery |
|
|
To ensure newsletter delivery, you
can add any additional
email addresses you may have to the OTC Journal Member List. Receiving
the OTC Journal Newsletter in multiple locations is the best way of making
sure you don't miss the next investing or trading opportunity! For web
based email addresses, the OTC Journal recommends @yahoo.com or @aol.com
for timely and reliable email newsletter delivery.
Note: Your email address will
be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition. |
|
|
|
The OTC Journal Newsletter is an
independent electronic publication committed to providing our readers with
factual information on selected publicly traded companies. All companies
are chosen on the basis of certain financial analysis and other pertinent
criteria with a view toward maximizing the upside potential for investors
while minimizing the downside risk, whenever possible. Moreover, as described
below, this publication accepts compensation from certain of the companies
which it features. MarketByte, LLC which owns this newsletter, also accepts
compensation in connection with the dissemination of information regarding
the companies featured. This newsletter should not, therefore, be regarded
as an independent publication.
Go Here to view our compensation
on every company we have ever covered, or visit the following web address:
http://www.otcjournal.com/disclosure/compensation/section/profile/
for
our full profiles and http://www.otcjournal.com/disclosure/compensation/section/alert/
for Trading Alerts.All statements and opinions expressed herein are those
of the editors and are subject to change without notice. A profile, description,
or other mention of a company in the newsletter is neither an offer nor
solicitation of an offer to buy or sell any securities mentioned. While
we believe all sources of information provided to us and contained in our
publication to be accurate and reliable, we cannot and do not guarantee
the accuracy of information we received from third parties. Larry Isen,
the editor and publisher of the OTC Journal, through various entities he
controls, has purchased 1,200,441 shares of Spicy Pickle at an average
cost of $.2125 per share. These purchases were made in Spicy Pickle private
offerings. The aforementioned purchases were made between August of 2005
and August of 2006. On 12/15/07, on entity controlled by Larry Isen participated
in an additional financing wherein 12 shares of convertible preferred,
converting at $.85 into 120,000 shares and 90,000 warrants with an exercise
price of $1.60 were purchased. In addition, Larry Isen has received 785,000
shares of Spicy Pickle common stock for consulting services and has purchased
213,343 shares in the open market at an average cost of $.89 cents per
share. In addition, MarketByte LLC, an entity controlled by Larry Isen,
has received a fee of $30,000 cash, and 300,000 newly issued restricted
shares for coverage of Spicy Pickle. TGR Group LLC, the publisher of the
Small Cap Network, has received $30,000 and 300,000 newly issued restricted
shares for coverage of Spicy Pickle. Mr. Isen is an affiliate of TGR Group.
In addition, two other individuals affiliated with TGR Group have purchased
a total of 300,000 shares at $.25 per share, 21,961 in the open market
at $.76 per share and received an additional 70,000 for consulting services.
Current positions of the aforementioned can be found at www.otcjournal.com
and www.smallcapnetwork.com in the Spicy Pickle information section.
From time to time MarketByte, LLC
sells shares in the open market it receives as compensation for coverage
of client companies. Since the shares are received as compensation for
services and not for investment purposes, the editors do not view the sale
of the shares as contradictory to any advice delivered in the content.
This should be viewed as a conflict of interest by shareholders or prospective
shareholders of the client companies.
The editor, members of the editor's
family, and/or entities with which they are affiliated aside from MarketBtye
LLC itself, are prohibited pursuant to company policy from owning, buying,
selling or otherwise trading stock for their own benefit in the companies
who appear in the publication unless such activities are specifically disclosed
in the newsletter.
THE READER SHOULD VERIFY ALL CLAIMS
AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED
IN THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES
A HIGH DEGREE OF RISK.
We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission ("SEC") at http://www.sec.gov
and/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com.
We also strongly recommend that you read the SEC advisory to investors
concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC's EDGAR page.
The NASD has published information on how to invest carefully at its web
site. MarketByte LLC's mailing address is 4653 Carmel Mtn Rd Suite 308
#402, San Diego, CA 92130.
The information found in this profile
is protected by the copyright laws of the United States and may not be
copied, or reproduced in any way without the express, written consent of
the editors of otcjournal.com.
You
can unsubscribe from this list at any time by Clicking
Here. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?. |
|
|
|
Click Here to View the OTC Journal Disclosure
|
|
To subscribe to our newsletter, please enter your email address below.
Quotes are delayed 20 minutes.
|